Who Owns WeightWatchers?
WeightWatchers is owned by WW International, Inc. (NASDAQ: WW), the public weight-management company founded by Jean Nidetch in 1963. The company shortened its consumer identity to WW in 2018 but now uses WeightWatchers prominently again. The parent owns the program, trademarks, apps, workshops, and clinical offering. It completed a financial reorganization in June 2025 and listed the reorganized company's new shares on Nasdaq under WW in July 2025.
Who Owns WeightWatchers?
- Parent Company: WW International
- Ownership Type: Wholly owned
- Company Type: Publicly Traded
- Stock Ticker: NASDAQ: WW
| Brand | Parent Company | Ownership Type |
|---|---|---|
| WeightWatchers | WW International | Wholly owned |
History of WeightWatchers
- Founded: 1963
- Founders: Jean Nidetch
Jean Nidetch founded Weight Watchers in Queens, New York, in 1963 after organizing group meetings around her own weight-loss experience. The workshop model used structured food guidance, weigh-ins, and peer support.
H.J. Heinz acquired Weight Watchers in 1978. European licensee Artal bought the business from Heinz in 1999, and Weight Watchers returned to public markets in 2001. The company expanded digital subscriptions as in-person meetings became a smaller part of the model.
The company adopted WW as its main identity in 2018 to signal a broader wellness focus. WeightWatchers later returned as the prominent consumer name. In 2023 the company acquired Sequence to add clinical weight care at a time when GLP-1 medicines were changing the market.
High debt and declining legacy subscriptions led WW International to file a prepackaged Chapter 11 case in May 2025. It emerged on June 24, 2025, after reducing debt, and the reorganized shares began Nasdaq trading in July.
About WW International
Is WW International publicly traded?
Yes, WW International, Inc. is publicly traded on Nasdaq under the ticker symbol WW. The company was delisted during its Chapter 11 bankruptcy filing in May 2025, then relisted on Nasdaq on July 8, 2025, after emerging from bankruptcy. The company had previously been publicly traded since 2004.
Why did WW file for bankruptcy?
WW filed for Chapter 11 bankruptcy in May 2025 to restructure approximately $1.6 billion in debt. The company's debt burden, combined with the disruption caused by GLP-1 weight loss medications to its traditional behavioral business, made the debt unsustainable. The reorganization eliminated $1.15 billion in debt, reducing total debt to $465 million.
What is the difference between WW and Weight Watchers?
WW is the rebranded name for Weight Watchers International, adopted in 2018 to reflect the company's evolution from a sole focus on weight loss to broader health and wellness. The legal name of the company is WW International, Inc. The Weight Watchers brand name is still used in consumer-facing marketing.
How many subscribers does WW have?
WW had 2.5 million total end-of-period subscribers as of Q2 2026. This includes 2.29 million behavioral subscribers (down 24.6 percent year over year) and 197,000 clinical subscribers (up 55.7 percent year over year). Core+ subscribers were 541,000, up 13.9 percent year over year.
Who is the CEO of WW International?
WW International is currently led by an Interim Office of the Chief Executive, with Jon Volkmann (Chief Operations Officer) and Felicia DellaFortuna (Chief Financial Officer) sharing executive responsibilities. The previous CEO, Tara Comonte, departed after the company's emergence from bankruptcy in 2025. The company is searching for a permanent CEO.
What is WW's Clinical business?
WW's Clinical business, operated through its Sequence subsidiary, provides telehealth access to clinicians who can prescribe GLP-1 weight management medications, lab work, and ongoing medical supervision. Clinical subscription revenue was $39.9 million in Q2 2026, up 30.4 percent year over year, and accounted for 24.6 percent of total revenue.
What is WW's revenue?
WW reported Q2 2026 revenue of $162.3 million, down 14.2 percent from $189.2 million in Q2 2025. The decline was driven by a 22.7 percent drop in behavioral subscription revenue, partially offset by 30.4 percent growth in clinical subscription revenue. The company has reaffirmed its full-year 2026 revenue and adjusted EBITDA guidance.
- Founded: 1963
- Headquarters: New York, New York, USA
- Company Type: Publicly Traded
- Stock: NASDAQ: WW
- Revenue: ~$700 million (FY2025 estimated)
- Employees: ~3,500
Where Is WeightWatchers Made / Based?
- Headquarters: New York, New York, USA
WeightWatchers Categories & Tags
WeightWatchers Ownership: Pros & Cons
Advantages
- +One parent can combine behavioral and clinical services
- +The brand has more than six decades of recognition
- +Public filings provide financial disclosure
- +Debt reduction gave the reorganized company more flexibility
Considerations
- -The 2025 reorganization canceled old shareholder equity
- -Clinical growth adds regulatory and medical-service risks
- -Weight management is highly competitive
- -Brand changes between Weight Watchers, WW, and WeightWatchers can confuse consumers
Frequently Asked Questions About WeightWatchers
Sources & Further Reading
Where to Buy
Disclosure: We may earn commission from purchases
WeightWatchers on AmazonCompetitors to WeightWatchers
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Herbalife | USA | 1980 | Mass market | Global | All-ages |
Learn More About Competitors
Competitive Analysis
Market Positioning: WeightWatchers competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Independent Alternatives to WeightWatchers
Looking for brands with different ownership structures? These similar brands are not owned by WW International, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsHerbalife
Owned by Herbalife Ltd.
Global nutrition and weight-management brand owned by Herbalife Ltd. and sold through independent distributors in more than 90 markets.
nutritiondietary-supplementsweight-management
Publicly Traded
Herbalife operates independently without a large parent corporation.
Healthcare PharmaceuticalsPharmacy Direct
Owned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
online-pharmacymail-orderdigital-health
Privately Owned
Pharmacy Direct is privately owned, unlike WeightWatchers which is under a publicly traded parent company.
Healthcare PharmaceuticalsAlcon
Owned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
eye-carecontact-lensesophthalmic
Publicly Traded
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsGE HealthCare
Owned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
healthcare-technologymedical-imagingdiagnostics
Publicly Traded
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsGoodRx
Owned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
prescription-savingshealthcare-technologydrug-prices
Publicly Traded
GoodRx operates independently without a large parent corporation.
Healthcare PharmaceuticalsMenicon
Owned by Menicon Co., Ltd.
Japan's first and largest contact lens manufacturer, founded in 1951 in Nagoya. Known for rigid gas permeable lenses, orthokeratology, and expanding daily disposable silicone hydrogel products.
contact-lensesvision-carergp-lenses
Publicly Traded
Menicon operates independently without a large parent corporation.
WW International Stock Information
Jobs at WW International
Latest News About WeightWatchers
Related Articles About WeightWatchers
View more articles
Pop Culture
Product Placement: The Brands Behind Your Favourite Films
165 brands backed Spider-Man: Brand New Day. Only 5 made it into the film. Global product placement spending hit $33 billion. Discover the brands behind your favourite films and who owns them. Explore our database.
Who Brands StaffAug 24, 2026
Product PlacementFilmsBrand Ownership
Pop Culture
Brands Featured in Netflix Shows and Who Owns Them
AB InBev signed a sweeping deal with Netflix. Genesis partnered with The Hawk. State Farm and DoorDash appeared in Running Point. Discover which brands are in Netflix shows and who owns them. Explore our database.
Who Brands StaffAug 23, 2026
NetflixProduct PlacementBrand Ownership
Consumer Education
Why Younger Consumers Research Brand Ownership Before Buying
72% of Gen Z trust customer reviews over influencer content. 94% of brands score lower on trust with Gen Z. Discover why younger consumers research brand ownership before buying. Explore our database.
Who Brands StaffAug 22, 2026
Gen ZMillennialsBrand Ownership
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Branddermatology
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription
Brandpharmaceutical
Activase
Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.
Brand in Healthcare & Pharmaceuticals
thrombolyticstroke-treatment